YOLFTbeta
INIFY Laboratories AB

INIFY Laboratories AB

INIFY · OL · Healthcare / Diagnostics & Research

5.00NOK+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close5.00
Open5.45
Day Range5.00 – 5.45
52-Week Range3.06 – 8.20
Volume6.34K
Market Cap714.71M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.82
Dividend Yield0.00%
50-Day Avg6.91
200-Day Avg5.36

About

INIFY Laboratories AB provides cancer diagnostics services in Sweden. It offers prostate cancer diagnostics services. The company was incorporated in 2021 and is based in Stockholm, Sweden.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Fredrik Palm
  • Employees0
  • HeadquartersHollandargatan 13, Stockholm, Sweden, 111 36, Norway
  • Websitehttps://www.inify.com

Leadership

  • Mr. Fredrik PalmChief Executive Officer · b. 1975
  • Ms. Ann-Charlotte LinderothChief Financial Officer · b. 1972
  • Emelie EdvigssonChief Operating Officer · b. 1983
  • Mr. Gunnar LathenChief Technology Officer
  • Dr. Claes LindhChief Medical Officer · b. 1979
  • Ms. Johanna KarlingChief Quality & Regulatory Affairs Officer · b. 1963
  • Mr. Magnus AurellChief Commercial Officer · b. 1964

Financials

Income Statement

Currency: SEK2023-12-312024-12-312025-12-31
Total Revenue1.19M13.13M22.01M
Growth (%)-+1000.67%+67.59%
Cost of Revenue341.00K1.88M3.40M
Gross Profit852.00K11.25M18.60M
Gross Margin71.42%85.68%84.54%
Operating Expense56.61M64.24M88.26M
Operating Income-55.76M-52.98M-69.66M
Operating Margin-4673.85%-403.51%-316.54%
EBITDA-48.97M-46.88M-62.95M
EBITDA Margin-4104.53%-357.01%-286.04%
Net Income-53.33M-51.64M-67.89M
Net Income Margin-4469.82%-393.29%-308.49%
Interest Expense0140.00K79.00K
Interest Expense % of Total Revenue0.00%1.07%0.36%

Balance Sheet

Currency: SEK2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets499.05K152.13M93.00M42.90M140.55M
Total Liabilities013.76M7.95M9.50M34.02M
Total Equity499.05K138.37M85.05M33.40M106.54M
Cash449.05K128.52M70.85M22.68M57.53M

Cash Flow

Currency: SEK2023-12-312024-12-312025-12-31
Operating Cash Flow--46.57M-42.86M
Capital Expenditure01.59M62.09M
Free Cash Flow--48.17M-104.94M
FCF to OCF-103.42%244.86%

Earnings

Report DateJun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023May 14, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 14, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------
EPS Actual-0.66-0.20-0.18-0.30-0.32-0.23-0.32-0.27-0.30-0.27-0.32-0.26-0.29-0.25-0.28-0.25-0.24
Surprise-----------------
Timing-------Pre-market---Pre-market-----

Key Statistics & Ratios

Market Cap714.71M
Enterprise Value557.85M
Trailing P/E0.00
Forward P/E0.00
Price / Sales28.45
Price / Book4.21
EPS-0.82
Revenue (TTM)0
Gross Profit (TTM)0
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-3768.22%
Return on Assets0.00%
Shares Outstanding107.47M
Shares Float0
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%